Battle For K-V Pharma Amps Up As Silver Point Boosts Offer

Law360, New York (May 31, 2013, 7:40 PM EDT) -- A group of senior bondholders led by Silver Point Finance LLC on Friday upped their offer to take control of the bankrupt K-V Pharmaceutical Co. in response to a group of investors that raised the stakes by increasing their own proposal just days ago.

The competition for the women's health care company and its subsidiaries, known for preterm birth prevention drug Makena, makes clear that investors expect great results once they exit bankruptcy. K-V has been scheduling and postponing court hearings for months as it attempts...
To view the full article, register now.